The US orphan drug programme 1983-1995. (Q33576656)

28 July 2017

1 reference

title

The US orphan drug programme 1983-1995. (English)

1 reference

28 July 2017

1 reference

Shulman SR

1

1 reference

PubMed ID

10170457

28 July 2017

Manocchia M

series ordinal

2

1 reference

28 July 2017

1 September 1997

1 reference

28 July 2017

1 reference

28 July 2017

12

1 reference

28 July 2017

3

1 reference

28 July 2017

312-326

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-199712030-00004

28 July 2017

0 references

cites work

The Orphan Drug Act. The first 7 years

1 reference

12 December 2020

The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?

1 reference

12 December 2020

The new drug approvals of 1993, 1994, and 1995: trends in drug development.

1 reference

12 December 2020

New drug development in the United States from 1963 to 1992

1 reference

12 December 2020

The new drug approvals of 1990, 1991, and 1992: trends in drug development

1 reference

12 December 2020

From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

12 December 2020

The Prescription Drug User Fee Act of 1992. A 5-year experiment for industry and the FDA.

1 reference

12 December 2020

10.2165/00019053-199712030-00004

Identifiers

DOI

1 reference

PubMed ID

10170457

Dimensions Publication ID

28 July 2017

0 references

1 reference

PubMed ID

10170457